The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Cancer Stem Cells: A Step Toward the Cure
Open accessAbstract
This special issue of Journal of Clinical Oncology is devoted to the emerging field of cancer stem cells (CSCs). The goal of this article is to introduce general concepts of CSC biology to clinicians, and to provide a framework for their understanding the CSC-based approach to the development of novel diagnostics, therapeutics, and prevention strategies in oncology. This new approach differs from the traditional one because the latter is based on the long-held concept that tumor formation and growth are due to increased proliferation of cells in cancers compared with normal tissues. This traditional view is supported by molecular oncology research during the last 50 years, which showed that tumors undergo a series of genetic events (mutations) that result in the activation or overexpression of genes promoting proliferation (eg, oncogenes), the silencing of genes involved in inhibition of proliferation (eg, tumor suppressor genes), and the development of the ability of cancer cells to elude apoptosis. The consequence is the development and unchecked growth of tumors and their progression to metastases. Based on this traditional concept of tumor growth, it has been disappointing that therapies designed to kill proliferating cells often fail to cure cancer patients. Furthermore, during tumor development, tissues accumulate a series of mutations over years or even decades, but, because of tissue renewal, most cells in tissues are lost or eliminated in just a brief time, typically days or weeks, and with their loss, any mutations they have acquired would also be lost. Thus, new mechanisms need to be considered to explain human tumorigenesis. One explanation is that tumorigenic mutations occur in cells that are few in number but reside long term in tissues. But that is not sufficient to explain tumorigenesis. To be truly tumorigenic, this population of rare, mutated cells would have to self-renew, clonally expand, and acquire additional mutations. It is now widely believed that these long-lived, uncommon cells are tissue stem cells (SCs) or cells derived from them that acquire the ability to self-renew. When mutated, they can become CSCs. Both normal SCs and CSCs may account for only a small fraction of cells ( 1%) in any given tissue or tumor. By definition, SCs are self-renewing. Mounting evidence presented in the articles in this special issue suggests that CSCs initiate and drive tumor growth. This is nothing less than a paradigm shift. It is a shift to the view that, first, cancers originate in tissue stem or progenitor cells through dysregulation of the self-renewal process. Second, throughout tumorigenesis, CSCs drive tumor growth. Third, current chemotherapeutic agents and radiation therapy largely target proliferating and differentiated cells that form the bulk of the tumor but not the relatively quiescent CSCs. Also, SCs are drug resistant and CSCs appear to be so too. Thus, this quiescence and resistance may account for many treatment failures. Fourth, if this is the case, then the only effective way to treat cancer is to target the CSC population. Although this view may seem novel, the basic idea that SCs are the cells of clonal origin of malignancies has existed for at least several decades, if not longer, particularly for leukemias and teratomas. Early attempts—beginning in the 1970s—to directly measure SCs in tumors used several approaches. One was mousespleen colony assays (eg, injection of lymphoma cells into mice with the appearance of lymphoma colonies in the spleen). A second was the counting of metastatic lung colonies after intravenous inoculation of tumor cells into mice. A third was tumor colony formation in vitro. However, this latter method produced mixed results for human tumors. SCs have also been known for decades to radiation biologists. More recent evidence, as presented in the articles in this special issue, supports an SC origin for solid tumors as well. In the following paragraphs, we discuss the properties of normal SCs and CSCs, and their possible roles in carcinogenesis and in mediating tumor behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Self-citationStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Self-citationIdentification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Phenotypic characterization of human colorectal cancer stem cells
Dalerba, P., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,184
Primary Bioassay of Human Tumor Stem Cells
Hamburger, A. W., & Salmon, S. E. (1977) · Science · doi:10.1126/science.560061 · Cited by 1,643
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Cancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378
Self-citationMigrating cancer stem cells — an integrated concept of malignant tumour progression
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1694 · Cited by 1,352
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F., & Dick, J. E. (2006) · Nature Medicine · doi:10.1038/nm1483 · Cited by 1,219
Glinsky, G. V., Berezovska, O., & Glinskii, A. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23412 · Cited by 916
Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
Eyler, C. E., & Rich, J. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1829 · Cited by 737
Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., Datar, R. H., & Cote, R. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0169 · Cited by 681
Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
Kakarala, M., & Wicha, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3931 · Cited by 403
Self-citationLee, C. J., Dosch, J., & Simeone, D. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6702 · Cited by 374
Roeder, I., Horn, M., Glauche, I., Hochhaus, A., Mueller, M. C., & Loeffler, M. (2006) · Nature Medicine · doi:10.1038/nm1487 · Cited by 334
Diverse mechanisms regulate stem cell self-renewal
Molofsky, A. V., Pardal, R., & Morrison, S. J. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.004 · Cited by 331
Origin of Testicular Teratomas From Primordial Germ Cells in Mice 2
(1967) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/38.4.549 · Cited by 320
Successful Therapy Must Eradicate Cancer Stem Cells
Dingli, D., & Michor, F. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0136 · Cited by 241
Sell, S., & Leffert, H. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5945 · Cited by 237
Evolution of Resistance During Clonal Expansion
Iwasa, Y., Nowak, M. A., & Michor, F. (2006) · Genetics · doi:10.1534/genetics.105.049791 · Cited by 233
Cancer Stem Cells: An Old Idea--A Paradigm Shift
Wicha, M. S., Liu, S., & Dontu, G. (2008) · AACR Education book · doi:10.1158/aacr.edb-can-05-3153 · Cited by 207
Self-citationHuman Colon Cancer Stem Cells: A New Paradigm in Gastrointestinal Oncology
Boman, B. M., & Huang, E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.6941 · Cited by 200
Self-citationA Stem Cell Model of Human Tumor Growth: Implications for Tumor Cell Clonogenic Assays 2
(1983) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/70.1.9 · Cited by 191
Brain Tumor Stem Cells: Bringing Order to the Chaos of Brain Cancer
Dirks, P. B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.6792 · Cited by 171
Glinsky, G. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0266 · Cited by 169
Fan, X., & Eberhart, C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2264 · Cited by 160
Ailles, L., Gerhard, B., Kawagoe, H., & Hogge, D. E. (1999) · Blood · doi:10.1182/blood.v94.5.1761 · Cited by 157
Mathematical Models of Cancer Stem Cells
Michor, F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2421 · Cited by 130
Cancer stem cells and “stemness” genes in neuro-oncology
Nicolis, S. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.022 · Cited by 126
How Dysregulated Colonic Crypt Dynamics Cause Stem Cell Overpopulation and Initiate Colon Cancer
Boman, B. M., Fields, J. Z., Cavanaugh, K. L., Guetter, A. A., & Runquist, O. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2061 · Cited by 108
Self-citationBoman, B. M., Wicha, M. S., Fields, J. Z., & Runquist, O. A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100202 · Cited by 95
Self-citationColonic Crypt Changes during Adenoma Development in Familial Adenomatous Polyposis
Boman, B. M., Walters, R., Fields, J. Z., Kovatich, A. J., Zhang, T., Isenberg, G. A., Goldstein, S. D., & Palazzo, J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63407-4 · Cited by 91
Self-citationComputer modeling implicates stem cell overproduction in colon cancer initiation.
Boman, B. M., Fields, J. Z., Bonham-Carter, O., & Runquist, O. A. (2001) · PubMed · Cited by 90
Self-citationEffect of Cellular Quiescence on the Success of Targeted CML Therapy
Komarova, N. L., & Wodarz, D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000990 · Cited by 86
Ultrastructural Analysis of the Early Development of Teratocarcinomas 2
Pierce, G. B., Stevens, L. C., & Nakane, P. K. (1967) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/39.4.755 · Cited by 73
Pierce, G. B., Nakane, P. K., Martínez-Hernández, A., & Ward, J. M. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/58.5.1329 · Cited by 70
Kopper, L., & Hajdú, M. (2004) · Pathology & Oncology Research · doi:10.1007/bf02893458 · Cited by 68
Breast cancer prognosis by combinatorial analysis of gene expression data
Alexe, G., Alexe, S., Axelrod, D. E., Bonates, T. O., Lozina, I., Reiß, M., & Hammer, P. L. (2006) · Breast Cancer Research · doi:10.1186/bcr1512 · Cited by 66
Kummermehr, J. C., & Trott, K.-R. (1997) · Elsevier eBooks · doi:10.1016/b978-012563455-7/50013-1 · Cited by 55
(2003) · PubMed
Cited by
Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., Fields, J. Z., Wicha, M. S., & Boman, B. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4418 · Cited by 1,045
Self-citationKurrey, N. K., Jalgaonkar, S. P., Joglekar, A. V., Ghanate, A. D., Chaskar, P. D., Doiphode, R. Y., & Bapat, S. A. (2009) · Stem Cells · doi:10.1002/stem.154 · Cited by 655
Silva, I. A., Bai, S., McLean, K., Yang, K., Griffith, K., Thomas, D., Ginestier, C., Johnston, C., Kueck, A., Reynolds, R. K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3175 · Cited by 514
Self-citationGidwani, B., & Vyas, A. (2015) · BioMed Research International · doi:10.1155/2015/198268 · Cited by 473
HOX genes and their role in the development of human cancers
Bhatlekar, S., Fields, J. Z., & Boman, B. M. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1181-y · Cited by 380
Self-citation
Metadata
- Authors
- Boman, B. M., & Wicha, M. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-06-10
- Volume
- 26
- Issue
- 17
- Pages
- 2795-2799
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2155522744
- Cited by
- 278
- References
- 45
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.